Company: BIAF
Filing Date: 2025-05-19
Form Type: 8-K
Source: 0001641172-25-011486
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-19
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01. Other Events.

bioAffinity
Technologies, Inc., a Delaware corporation (the “ Company”), currently plans to hold its 2025 Annual Meeting of Stockholders
(the “2025 Annual Meeting”) on July 25, 2025. The Company intends to set the record date for determining the stockholders
of record who will be entitled to vote at the 2025 Annual Meeting as the close of business on May 29, 2025. The time and location of
the 2025 Annual Meeting will be as set forth in the Company’s definitive proxy statement for the 2025 Annual Meeting to be filed
with the Securities and Exchange Commission.

Because
the scheduled date of the 2025 Annual Meeting is more than 30 days after the anniversary of the Company’s 2024 annual meeting of
stockholders, prior disclosed deadlines regarding the submission of stockholder proposals pursuant to Rule 14a-8 (“ Rule 14a-8”)
under the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), for the 2025 Annual Meeting are no longer applicable.
The Company is hereby providing notice of certain revised deadlines for the submission of stockholder proposals in connection with the
2025 Annual Meeting. In order for a stockholder proposal, submitted pursuant to Rule 14a-8, to be considered timely for inclusion in
the Company’s proxy statement and form of proxy for the 2025 Annual Meeting, such proposal must be received by the Company by May
26, 2025. The Company has determined that May 26, 2025 is a reasonable time before the Company plans to begin printing and mailing its
proxy materials. Therefore, in order for a stockholder to submit a proposal for inclusion in the Company’s proxy materials for
the 2025 Annual Meeting, the stockholder must comply with the requirements set forth in Rule 14a-8, including with respect to the subject
matter of the proposal, and must deliver the proposal and all required documentation to the Company no later than May 26, 2025. The public
announcement of an adjournment or postponement of the date of the 2025 Annual Meeting will not commence a new time period (or extend
any time period) for submitting a proposal pursuant to Rule 14a-8.

Generally,
timely notice of any director nomination or other proposal that any stockholder intends to present at the 2025 Annual Meeting, but does